questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Hypersensibilité retardée : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hypersensibilité retardée
Tests cutanés
Tests de patch
Lymphocytes T
Éruption cutanée
Réaction allergique
Analyse sanguine
Inflammation
Antécédents médicaux
Allergènes
Symptômes
5
Éruption cutanée
Démangeaisons
Réaction retardée
Allergène
Symptômes systémiques
Fatigue
Réaction cutanée
Vésicules
Variabilité des symptômes
Réaction individuelle
Prévention
5
Tests d'allergie
Prévention des réactions
Changements de mode de vie
Allergènes alimentaires
Antihistaminiques
Prévention
Gestion des allergies
Médicaments d'urgence
Traitements
5
Corticostéroïdes
Évitement des allergènes
Antihistaminiques
Démangeaisons
Corticostéroïdes
Inflammation
Traitements topiques
Pommades corticostéroïdes
Traitement pédiatrique
Hypersensibilité
Complications
5
Infections cutanées
Complications
Maladies chroniques
Réactions répétées
Anaphylaxie
Réactions sévères
Qualité de vie
Démangeaisons
Hospitalisation
Traitement intensif
Facteurs de risque
5
Facteurs de risque
Antécédents d'allergies
Professions à risque
Produits chimiques
Antécédents familiaux
Allergies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypersensibilité retardée : Questions médicales les plus fréquentes",
"headline": "Hypersensibilité retardée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypersensibilité retardée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité",
"url": "https://questionsmedicales.fr/mesh/D006967",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité",
"code": {
"@type": "MedicalCode",
"code": "D006967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Eczéma de contact allergique",
"alternateName": "Dermatitis, Allergic Contact",
"url": "https://questionsmedicales.fr/mesh/D017449",
"about": {
"@type": "MedicalCondition",
"name": "Eczéma de contact allergique",
"code": {
"@type": "MedicalCode",
"code": "D017449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dermatite photoallergique",
"alternateName": "Dermatitis, Photoallergic",
"url": "https://questionsmedicales.fr/mesh/D017454",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite photoallergique",
"code": {
"@type": "MedicalCode",
"code": "D017454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dermatite de contact au Rhus toxicodendron",
"alternateName": "Dermatitis, Toxicodendron",
"url": "https://questionsmedicales.fr/mesh/D011040",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite de contact au Rhus toxicodendron",
"code": {
"@type": "MedicalCode",
"code": "D011040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"alternateName": "Sarcoidosis",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"url": "https://questionsmedicales.fr/mesh/D017565",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uvéoparotidite",
"alternateName": "Uveoparotid Fever",
"url": "https://questionsmedicales.fr/mesh/D014608",
"about": {
"@type": "MedicalCondition",
"name": "Uvéoparotidite",
"code": {
"@type": "MedicalCode",
"code": "D014608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.865"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée",
"alternateName": "Hypersensitivity, Delayed",
"code": {
"@type": "MedicalCode",
"code": "D006968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth J Phillips",
"url": "https://questionsmedicales.fr/author/Elizabeth%20J%20Phillips",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org."
}
},
{
"@type": "Person",
"name": "Shuen-Iu Hung",
"url": "https://questionsmedicales.fr/author/Shuen-Iu%20Hung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw."
}
},
{
"@type": "Person",
"name": "Andrew Gibson",
"url": "https://questionsmedicales.fr/author/Andrew%20Gibson",
"affiliation": {
"@type": "Organization",
"name": "Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia."
}
},
{
"@type": "Person",
"name": "Chuang-Wei Wang",
"url": "https://questionsmedicales.fr/author/Chuang-Wei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Wen-Hung Chung",
"url": "https://questionsmedicales.fr/author/Wen-Hung%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37194281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0284186X.2023.2212411"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lung neuroendocrine neoplasms: a single centre surgical series and analysis of staging.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37106553",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ans.18493"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36307533",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41571-022-00696-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis.",
"datePublished": "2024-08-17",
"url": "https://questionsmedicales.fr/article/39201642",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25168957"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38693435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00262-024-03704-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypersensibilité retardée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypersensibilité retardée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypersensibilité retardée",
"description": "Comment diagnostiquer l'hypersensibilité retardée ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent une hypersensibilité retardée ?\nPeut-on diagnostiquer par des analyses sanguines ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypersensibilité retardée",
"description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes systémiques ?\nComment se manifeste une réaction cutanée ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypersensibilité retardée",
"description": "Comment prévenir l'hypersensibilité retardée ?\nLes tests d'allergie aident-ils à la prévention ?\nLes changements de mode de vie sont-ils nécessaires ?\nLes médicaments préventifs sont-ils disponibles ?\nComment gérer les expositions accidentelles ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypersensibilité retardée",
"description": "Quel est le traitement principal de l'hypersensibilité retardée ?\nLes antihistaminiques sont-ils efficaces ?\nComment les corticostéroïdes aident-ils ?\nY a-t-il des traitements topiques recommandés ?\nLes traitements sont-ils différents pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypersensibilité retardée",
"description": "Quelles complications peuvent survenir ?\nL'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque d'anaphylaxie ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypersensibilité retardée",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque d'hypersensibilité ?\nLes professions exposées sont-elles à risque ?\nLe stress peut-il aggraver l'hypersensibilité ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Lung+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypersensibilité retardée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests cutanés spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de patch et les tests de stimulation lymphocytaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hypersensibilité retardée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et rougeurs apparaissent après exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des analyses sanguines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines ne sont pas spécifiques, mais peuvent aider à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les allergènes potentiels et les antécédents d'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruptions cutanées, démangeaisons, et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils immédiatement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils apparaissent généralement 24 à 72 heures après l'exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réaction cutanée ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réaction cutanée se manifeste par des rougeurs, des vésicules et un gonflement localisé."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypersensibilité retardée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition aux allergènes connus est la meilleure méthode de prévention."
}
},
{
"@type": "Question",
"name": "Les tests d'allergie aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests d'allergie peuvent identifier les allergènes à éviter pour prévenir les réactions."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme éviter certains aliments ou produits, peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les médicaments préventifs sont-ils disponibles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques peuvent être pris en prévention avant une exposition connue."
}
},
{
"@type": "Question",
"name": "Comment gérer les expositions accidentelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir un plan d'action et des médicaments d'urgence peut aider à gérer les expositions accidentelles."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'hypersensibilité retardée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal consiste en l'évitement de l'allergène et l'utilisation de corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les antihistaminiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antihistaminiques peuvent soulager les démangeaisons, mais ne traitent pas la cause."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes réduisent l'inflammation et soulagent les symptômes cutanés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements topiques recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crèmes ou pommades corticostéroïdes peuvent être appliquées sur les zones affectées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections cutanées peuvent survenir si les lésions sont grattées."
}
},
{
"@type": "Question",
"name": "L'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions répétées peuvent contribuer à des maladies cutanées chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'anaphylaxie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anaphylaxie est rare dans l'hypersensibilité retardée, mais des réactions sévères peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent entraîner des douleurs, des démangeaisons et une gêne sociale."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une hospitalisation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, une hospitalisation peut être nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'exposition répétée et la génétique sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypersensibilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les professions exposées sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines professions, comme celles en contact avec des produits chimiques, présentent un risque accru."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypersensibilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter la sensibilité aux allergènes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial d'allergies peut augmenter le risque d'hypersensibilité retardée."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org.
Publications dans "Hypersensibilité retardée" :
3 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw.
Publications dans "Hypersensibilité retardée" :
3 publications dans cette catégorie
Affiliations :
Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
Clinical Immunology and Allergy, McGill University Health Center, Montréal, Canada.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
IRCCS Oasi Maria S.S., Troina, Italy.
Fondazione Mediterranea G.B. Morgagni, Italy.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
département de Dermatologie et Allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP.Sorbonne Université, Hôpital Tenon, Paris F75020, France. Electronic address: annick.barbaud@aphp.fr.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Pharmacy Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Research and Teaching Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Austin Health, Center for Antibiotic Allergy and Research, Heidelberg, VIC, Australia.
Department of Oncology, Sir Peter MacCallum Cancer Center, The University of Melbourne, Parkville, VIC, Australia.
Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.
The National Center for Infections in Cancer, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Allergy, Zhongnan Hospital of Wuhan University, Wuhan, China.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Department of Immunology, Hospital de la Princesa, Health Research Institute of Princesa Hospital (ISS-IP), Autonomous University of Madrid, 28006 Madrid, Spain.
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eberhard Karls University, 72076 Tübingen, Germany.
Publications dans "Hypersensibilité retardée" :
Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work...
To review the outcomes of surgically resected lung neuroendocrine neoplasms (LNEN) at a tertiary referral centre and to validate a previously published LNEN-specific staging system (NETL)....
All patients who were identified on histopathology to have LNEN were included. Pre-, intra- and post-operative outcomes were collected, including long-term survival. Patients were staged by both the T...
A total of 132 patients were included in the study, with a median age of 65 years; 55% were female. Typical carcinoid (TC) was the most common pathology (53.4%) followed by large cell neuroendocrine c...
This is the largest known Australian series of LNEN to date, showing survival comparable to international outcomes. We have demonstrated large variations in outcome, driven by histological grade. The ...
Neuroendocrine neoplasms (NENs) can develop in almost any organ and span a spectrum from well-differentiated and indolent neuroendocrine tumours (NETs) to poorly differentiated and highly aggressive n...
Lung neuroendocrine neoplasms (L-NEN) are heterogeneous tumors. While bone metastases (BM) have been associated with worse prognosis in other NEN, their role in L-NEN deserves in-depth analysis. This ...
Advancements in immunotherapeutic approaches only had a modest impact on the therapy of lung neuroendocrine neoplasms (LNENs). Our multicenter study aimed to investigate the expression patterns of nov...
The expressions of V-domain Ig suppressor of T cell activation (VISTA), OX40L, Glucocorticoid-induced TNF receptor (GITR), and T cell immunoglobulin and mucin domain 3 (TIM3) proteins were measured by...
Tumor cell TIM3 expression was the highest in ACs (p < 0.001), whereas elevated tumor cell GITR levels were characteristic for both ACs and SCLCs (p < 0.001 and p = 0.011, respectively). OX40L express...
LNEN subtypes have characteristic and widely divergent VISTA, OX40L, GITR, and TIM3 protein expressions. By shedding light on the different expression patterns of these immunotherapy targets, the curr...
Although immunotherapy has led to a paradigm shift in the treatment of lung cancer, the therapeutic approaches for lung neuroendocrine neoplasms (LNENs) are still limited. Our aim was to explore the i...
Surgically removed tumor samples of 26 atypical carcinoid (AC), 30 large cell neuroendocrine carcinoma (LCNEC) and 29 small cell lung cancer (SCLC) patients were included. The immune phenotype of each...
Unsupervised hierarchical clustering revealed distinct immunologic profiles across tumor types. Specifically, AC tumors were characterized by high tumor cell CD40 expression and low levels of immune i...
By providing insights into the widely divergent immunologic profiles of LNENs, our results might serve as a basis for the development of novel immunotherapy-related approaches in these devastating mal...
Enhanced recovery after surgery programs have reduced complications and shortened hospital stays after lung resection. This study aimed to determine whether video-assisted thoracoscopic surgery perfor...
This retrospective, propensity-matched, cohort analysis was conducted from January 2020 to August 2020. Among 959 patients who underwent video-assisted thoracoscopic surgery, 739 underwent inpatient s...
Propensity matching estimated 218 patients in each group. The mean length of hospital stay was shorter in the two-day surgery group (2.17 ± 0.89 days) than in the inpatient surgery group (6.31 ± 2.13 ...
Two-day surgery is a safe, feasible, and cost-effective procedure for selected patients with lung neoplasms when combined with accurate preoperative evaluations, successful intraoperative assessments,...
Recently, advancement of somatostatin receptor (SSTR) imaging and theragnostic approach using peptide receptor radionuclide therapy (PRRT) have changed the paradigm of diagnosis and management of neur...
Metastasis to the thyroid gland is very uncommon with an incidence of 2-3% of all thyroid malignancies. A higher incidence is noted in autopsy studies indicating incidental detection. However, tumour-...
The roles of cyclin-dependent kinase 6 (CDK6) in various cancers, including small cell lung carcinoma (SCLC), remain unclear. Here, 111,54 multi-center samples were investigated to determine the expre...